4 ms·
Rejoice, for pfizermectin is now upon us. Did they at least test the study participants for natural immunity ahead of time? In related news, Merck's molnupirav
by m0zg 5y ago
Rejoice, for pfizermectin is now upon us. Did they at least test the study participants for natural immunity ahead of time?
In related news, Merck's molnupiravir has been approved in the UK as well.
- lern_too_spel 5y agoWhy would that matter? Treatment is randomly assigned.
- m0zg 5y agoBecause you can't trust Pfizer, unfortunately. Here's how they run their "studies" nowadays: https://www.bmj.com/content/375/bmj.n2635 https://www.bmj.com/content/375/bmj.n2635. This is just one lab, nobody has come forward (yet) about others, and given that the whistleblower has been fired right away, chances of other whistleblowers coming forward are pretty low. Be that as it may, I regard whatever they say about safety or efficacy of their products the same way I did in 2019 - with extreme suspicion.
- lern_too_spel 5y agoThen your criticism makes even less sense. If they tested for natural immunity, they could put the people who have natural immunity in the vaccine group.